Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance and Reinduction Chemotherapy With Avastin in Metastatic Colon Cancer
NCT00797485Phase 3Unknown
- Sponsor
- Southern Italy Cooperative Oncology Group
- Start
- Jul 2008
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bevacizumab in metastatic colorectal cancer (mCRC) (2 arms), sponsored by Southern Italy Cooperative Oncology Group. Primary endpoint: Time to failure of strategy. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00797485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797485.